IMM 6.25% 30.0¢ immutep limited

Ann: Immutep granted Chinese patent for its LAG-3 candidate Efti, page-81

  1. 465 Posts.
    lightbulb Created with Sketch. 100

    The below is this morning's * themes on the biotech space.

    There has being a few comments on HC basically stating buying on the "news and selling on the facts" which was a well known theme with immutep in the past. IMO, I think this time will be different; firstly we are more advance clinically enduring a risk off from past times. Secondly we have now predators watching our stock thus creating the FOMO of possible partnership or TO'S. I for one this time will be holding on. GLTLTH...



    https://unauthorised investment advice/health/scopos-powerplays-the-immune-oncology-space-finally-gets-long-overdue-attention/?utm_medium=email&utm_campaign=Weekend%20email%20-%20Saturday%20May%2029&utm_content=Weekend%20email%20-%20Saturday%20May%2029+CID_1fe50a1de3c5128b9a03b056181e47d8&utm_source=Campaign%20Monitor&utm_term=Read%20More
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.020(6.25%)
Mkt cap ! $435.7M
Open High Low Value Volume
31.5¢ 31.5¢ 29.5¢ $2.355M 7.796M

Buyers (Bids)

No. Vol. Price($)
8 128197 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 100000 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.